The study eventually proposes a novel transcriptional phenotype of ETP-ALL as: KIT+HGF+ANPEP+NT5E+CDH2−PROM1+CXCL2+CD33+IL1B+, which might be used in conjunction with the conventional biomarkers (Coustan-Smith et al., 2009). The gene discussed is CXCL2; the disease is acute lymphoblastic leukemia.